logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
L

Ling Li

Inner Mongolia Agricultural University
H指数:31
被引数:3,150

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SDH, a novel diarylheptane compound, alleviates dextran sulfate sodium (DSS)-induced colitis by reducing Th1/Th2/Th17 induction and regulating the gut microbiota in mice

SDH是一种新型二芳基庚烷化合物，通过减少小鼠Th1/Th2/Th17诱导和调节肠道菌群来缓解葡聚糖硫酸钠 (DSS) 诱导的结肠炎

INTERNATIONAL IMMUNOPHARMACOLOGY
IF4.7
2024-06-010
PRE
Yang, Fei; Zhang, Minjie; Xu, Ruyi; Yu, Yunhui; Feng, Haimei; Li, Dong; Li, Ling; Zhang, Biyan; Liu, Gang; Wang, Yanping; Xie, Qing; Chen, Zijun; Cao, Yu; Li, Yunsen
Orelabrutinib-bruton tyrosine kinase inhibitor-based regimens in the treatment of central nervous system lymphoma: a retrospective study

奥列拉布替尼-布鲁顿酪氨酸激酶抑制剂方案治疗中枢神经系统淋巴瘤的回顾性研究

INVESTIGATIONAL NEW DRUGS
IF2.7
2022-02-0921
PRE
Wu, Jing-Jing; Wang, Wen-Hua; Dong, Meng; Ma, Shan-Shan; Zhang, Xu-Dong; Zhu, Li-Nan; Niu, Song-Tao; Ding, Meng-Jie; Zhang, Jie-Ming; Zhang, Lei; Li, Xin; Li, Ling; Sun, Zhen-Chang; Wang, Xin-Hua; Fu, Xiao-Rui; Li, Zhao-Ming; Chang, Yu; Nan, Fei-Fei; Yan, Jia-Qin; Yu, Hui; Wu, Xiao-Long; Zhou, Zhi-Yuan; Zhang, Ming-Zhi
Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial

以福莫司汀为基础的治疗与利妥昔单抗联合作为一线诱导化疗，然后进行WBRT治疗新诊断的原发性中枢神经系统淋巴瘤: 一项前瞻性II期试验

CANCER BIOLOGY & MEDICINE
IF8.4
2021-10-121
OAAI
Wu, Jingjing; Gao, Fenghua; Wang, Wenhua; Zhang, Xudong; Dong, Meng; Zhang, Lei; Li, Xin; Li, Ling; Sun, Zhenchang; Wang, Xinhua; Fu, Xiaorui; Zhu, Linan; Ding, Mengjie; Niu, Songtao; Li, Zhaoming; Chang, Yu; Nan, Feifei; Yan, Jiaqian; Yu, Hui; Wu, Xiaolong; Zhou, Zhiyuan; Zhang, Jieming; Zhang, Mingzhi
Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure
FRONTIERS IN ONCOLOGY
IF3.3
2021-06-189
OAAI
Hu, Junxia; Wang, Xin; Chen, Fei; Ding, Mengjie; Dong, Meng; Yang, Wanqiu; Yin, Meifeng; Wu, Jingjing; Zhang, Lei; Fu, Xiaorui; Sun, Zhenchang; Li, Ling; Wang, Xinhua; Li, Xin; Guo, Shuangshuang; Zhang, Dianbao; Lu, Xiaohui; Leng, Qing; Zhang, Mingzhi; Zhu, Linan; Zhang, Xudong; Chen, Qingjiang
Research on the midterm efficacy and prognosis of patients with diffuse large B-cell lymphoma by different evaluation methods in interim PET/CT

中期PET/CT不同评估方法对弥漫大b细胞淋巴瘤患者中期疗效及预后的研究

EUROPEAN JOURNAL OF RADIOLOGY
IF3.3
2020-12-0110
PREAI
Li, Xingying; Xie, Xinli; Zhang, Lei; Li, Xin; Li, Ling; Wang, Xinhua; Fu, Xiaorui; Sun, Zhenchang; Zhang, Xudong; Li, Zhaoming; Wu, Jingjing; Yu, Hui; Chang, Yu; Yan, Jiaqin; Zhou, Zhiyuan; Nan, Feifei; Wu, Xiaolong; Tian, Li; Zhang, Mingzhi
Radiotherapy vs sequential pegaspargase, gemcitabine, cisplatin and dexamethasone and radiotherapy in newly diagnosed early natural killer/T-cell lymphoma: A randomized, controlled, open-label, multicenter study
INTERNATIONAL JOURNAL OF CANCER
IF4.7
2020-10-1912
OAAI
Zhang, Lei; Wang, Yan; Li, Xin; Li, Ling; Wang, Xinhua; Sun, Zhenchang; Wu, Jingjing; Fu, Xiaorui; Zhang, Xudong; Yu, Hui; Wang, Guannan; Chang, Yu; Yan, Jiaqin; Zhou, Zhiyuan; Wu, Xiaolong; Nan, Feifei; Li, Wencai; Zhang, Mingzhi

研究方向

暂未获取到该数据
M
Mingzhi Zhang
H 指数:38论文数:359被引数:5,484
X
Xiaorui Fu
H 指数:24论文数:149被引数:2,124
W
Wu, Jingjing
H 指数:0论文数:3被引数:70
X
Xinhua Wang
H 指数:40论文数:370被引数:5,714
X
Xudong Zhang
H 指数:22论文数:142被引数:1,985
Y
Yu Chang
H 指数:32论文数:148被引数:3,661
J
Jiaqin Yan
H 指数:18论文数:107被引数:1,173
K
Ken H. Young
H 指数:80论文数:621被引数:2.7万
Z
Zhi‐Yuan Zhou
H 指数:36论文数:279被引数:5,544
L
Lei Zhang
H 指数:22论文数:106被引数:1,650